What receptors do the antiemetic medications Zofran (ondansetron), Reglan (metoclopramide), Phenergan (promethazine), Haldol (haloperidol), and droperidol act on?

Receptor Mechanisms of Common Antiemetic Medications

Each of these nausea medications works through distinct receptor pathways, with Zofran blocking serotonin receptors, Reglan acting on both dopamine and acetylcholine pathways, Phenergan targeting histamine and acetylcholine receptors, while Haldol and droperidol primarily antagonize dopamine receptors.

Zofran (Ondansetron)

Primary mechanism: Selective 5-HT₃ (serotonin) receptor antagonist 1

• Blocks serotonin receptors in two key locations:
  • Centrally: Chemoreceptor trigger zone in the area postrema and nucleus tractus solitarius 1, 2
  • Peripherally: Vagal nerve terminals in the gastrointestinal tract 1, 2
• Not a dopamine receptor antagonist 1
• Works by preventing serotonin (released from enterochromaffin cells during chemotherapy or other triggers) from stimulating vagal afferents that initiate the vomiting reflex 1

Reglan (Metoclopramide)

Dual mechanism: Dopamine D₂ receptor antagonist + prokinetic effects 3

• Primary antiemetic action: Antagonizes dopamine receptors in the chemoreceptor trigger zone (CTZ), blocking dopamine-induced nausea and vomiting 3
• Secondary mechanism: Sensitizes tissues to acetylcholine, enhancing gastrointestinal motility 3
• Increases lower esophageal sphincter tone and accelerates gastric emptying 3
• The dopamine antagonism is responsible for both antiemetic effects and potential extrapyramidal side effects 3

Phenergan (Promethazine)

Multiple receptor antagonism: H₁ histamine receptor antagonist + anticholinergic effects 4

• Primary mechanism: Competitive H₁ receptor antagonist 4
• Secondary effects: Anticholinergic, antiemetic, and sedative properties 4
• Has relatively weak dopamine antagonist properties (1/10th that of chlorpromazine) due to structural differences from neuroleptic phenothiazines 4
• The combination of antihistaminic and anticholinergic effects contributes to its antiemetic action 5

Haldol (Haloperidol) and Droperidol

Primary mechanism: Dopamine D₂ receptor antagonists (butyrophenones) 5, 6

• Block dopamine receptors in the chemoreceptor trigger zone, preventing dopamine-mediated stimulation of nausea and vomiting 5
• Both are classified as antipsychotics but are used for antiemetic purposes at lower doses 5
• Droperidol has been shown to be more effective than some other antiemetics but carries an FDA black box warning for QT prolongation, limiting its use to refractory cases 7, 8
• Haldol at doses of 0.5-2 mg is used for breakthrough nausea 9

Clinical Context from Guidelines

The 2025 AGA guideline emphasizes that patients with gastroparesis may need antiemetics as needed, including 5-HT₃ antagonists (ondansetron), histamine H₁ antagonists (promethazine), and/or dopamine D₂ antagonists (prochlorperazine) 10. These agents reduce nausea and vomiting without affecting gastric emptying 10.

The 2022 AGA guideline notes that phenothiazine antipsychotics reduce nausea and vomiting by inhibiting dopamine receptors in the brain 11, while 5-HT₃ receptor antagonists block serotonin receptors in the chemoreceptor trigger zone and inhibit vagal afferents 11.

Important Caveats:

• Ondansetron has no effect on gastrointestinal motility and does not alter plasma prolactin concentrations 1
• Metoclopramide carries an FDA black box warning for tardive dyskinesia risk 10
• Promethazine should be given via central line only when administered IV due to risk of vascular damage 9
• Droperidol and haloperidol can prolong QT interval and cause extrapyramidal side effects 6, 7